Evidence map›Paper›PMID 35877814›Full record

ArticleAnnals of neurology2022

Elevated Plasma Phosphorylated Tau 181 in Amyotrophic Lateral Sclerosis.

Katheryn A Q Cousins, Leslie M Shaw, Sanjana Shellikeri, Laynie Dratch, Luis Rosario, Lauren B Elman, Colin Quinn, Defne A Amado, David A Wolk, Thomas F Tropea and 6 more

Open access · greenAbstract read
In one paragraph

Article in Annals of neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Brain-derived plasma p-tau217 shows enhanced dynamic range for Alzheimer's disease neuropathological change.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Head-to-head comparison of brain-derived pTau217 and total pTau217 for brain amyloid and tau pathology classification.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Comparison of plasma p-tau217/Aβ42, p-tau217, and Aβ42/Aβ40 biomarkers by race to detect Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Katheryn A Q CousinsDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.ORCID 0000-0003-1879-2766
Leslie M ShawDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA.
Sanjana ShellikeriDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Laynie DratchDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Luis RosarioDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Lauren B ElmanDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Colin QuinnDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Defne A AmadoDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
David A WolkDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Thomas F TropeaDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Alice Chen-PlotkinDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
David J IrwinDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.ORCID 0000-0002-5599-5098
Murray GrossmanDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Edward B LeeDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA.
John Q TrojanowskiDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA.
Corey T McMillanDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
University of Pennsylvania · US

Funding

Research Education ComponentP30AG072979 · NIA · UNIVERSITY OF PENNSYLVANIA · PI DAVID A WOLK · 2021 to 2026
$24.8M
Understanding Environmental Contributions to Heterogeneity in bvFTD.P01AG066597 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Lauren M Massimo · 2020 to 2026
$18.8M
Project IV "Tackling Heterogeneity of Cognitive Trajectory in LBD"U19AG062418 · NIA · UNIVERSITY OF PENNSYLVANIA · PI TROJANOWSKI, JOHN Q. · 2019 to 2023
$18.1M
Spreading Tau Pathology in Non-Amnestic Alzheimer's DiseaseR01AG054519 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Jeffrey S Phillips · 2018 to 2026
$7.4M
Connectomic imaging in familial and sporadic frontotemporal degenerationU01AG052943 · NIA · UNIVERSITY OF PENNSYLVANIA · PI GORNO TEMPINI, MARIA LUISA, GROSSMAN, MURRAY · 2016 to 2019
$5.9M
Biomarkers of cognitive decline in Parkinson's DiseaseR01NS115139 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI CHEN-PLOTKIN, ALICE S · 2019 to 2023
$3.6M
Viral-based Therapeutic Approaches for Reversal of ALS PathologyK08NS114106 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI AMADO, DEFNE AUDREY · 2020 to 2024
$1.1M
The Role of Alzheimer's Disease Genetic Risk in Predicting Parkinson's Disease DementiaK23NS114167 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI TROPEA, THOMAS FRANCIS · 2020 to 2024
$985k
NIA NIH HHS P01 AG066597NIA NIH HHS P30 AG072979NIA NIH HHS R01 AG054519NIA NIH HHS U01 AG052943NIA NIH HHS U19 AG062418NINDS NIH HHS K08 NS114106NINDS NIH HHS K23 NS114167NINDS NIH HHS R01 NS115139
6 · The paper itself

Abstract

objectivePlasma phosphorylated tau (p-tau

methodsPatients were clinically or pathologically diagnosed with ALS (n = 130) or AD (n = 79), or were healthy non-impaired controls (n = 26). Receiver operating characteristic (ROC) curves were analyzed and area under the curve (AUC) was used to discriminate AD from ALS. Within ALS, Mann-Whitney-Wilcoxon tests compared analytes by presence/absence of upper motor neuron and lower motor neuron (LMN) signs. Spearman correlations tested associations between plasma p-tau

resultsA Wilcoxon test showed plasma p-tau

interpretationWe found strong evidence that plasma p-tau

Indexed as

Alzheimer DiseaseAmyotrophic Lateral SclerosisArea Under CurveBiomarkersHumansNerve DegenerationROC Curvetau ProteinsBiomarkerstau Proteins

Identifiers

PMID35877814
PMCPMC9588516
OpenAlexW4287510446

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.